We are thrilled to announce that ICE Bioscience will be exhibiting at the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, taking place from October 23-25, 2024, at the CCIB in Barcelona, Spain. This prestigious event brings together global leaders in oncology, drug development, and molecular biology to explore cutting-edge innovations in cancer research.

Visit Us at Booth 13

We invite all attendees to stop by Booth 13 to learn more about our cancer research solutions. 

Join us for cutting-edge insights on drug discovery at the Poster Session: "Drug Screening" on Friday, 25 October 2024.

Here's a sneak peek at our poster presentations:

1. High-throughput 2D and 3D cell panel screening to facilitate RAS target drug discovery and development (Poster No. PB385)

2. KAT6A inhibitor screening cascade to facilitate novel drug discovery (Poster No. PB384)

3. A WRN screening cascade to facilitate novel drug discovery (Poster No. PB321)

4. PARP1 inhibitor resistant cell line generation and DDR cell panel development (Poster No. PB322)

5. The establishment of AR cell-based and biochemical assays facilitates novel drug discovery in prostate cancer and breast cancer (Poster No. PB382)

6. METTL3 inhibitors screening cascade for new drug discovery (Poster No. PB383)